|Autoimmune|| Multiple Sclerosis / Risk
| ||Dr. George Gillson, M.D., Ph.D., reports that after six weeks of treatment with histamine in 19 individuals with multiple sclerosis|
The nurse responsible for the revival of the use of histamine, Elaine DeLack, MS, RN, has collected verbal reports from over 200 individuals diagnosed with multiple sclerosis who have used histamine: 72% report at least one significant improvement in symptoms, and some many more.
- 11 noted dramatic improvement
- 3 reported one or more significant improvements in symptoms, including reduced numbness, better motor control, improved speech, much better sleeping, and more energy
- 1 had no change
- 4 had no change due to poor absorption of the histamine, poor patch adhesion, or an interfering drug.
Another study, which was published in the February, 2002 issue of Multiple Sclerosis, followed the conditions of 27 MS sufferers over 12 weeks. Of those, 22 took Procarin and the other five a placebo. The Procarin group, according to the journal, showed an average 37% reduction in fatigue, results some experts say would be significant if confirmed in a larger study. Procarin (Prokarin) is currently being used in a patch form to deliver the cream through the skin.
| ||Histamine diphosphate therapy at 2.75mg in 500cc of 5% dextrose solution given in a slow intravenous infusion can relieve an episode of severe dizziness and nausea due to Meniere's disease. Periodic infusions can lengthen the interval between these episodes. At the University of Maryland Medical System's Looper Clinic, this therapy is performed on 4 to 6 patients each week. ["IV Histamine for Meniere's", Guyther, J. Roy, M.D., Cortlandt Forum, May 1994;78 75-8]|
(Address: J. Roy Guyther, M.D., 150 Lockshill Rd., Mechanicsville, MD 20659, U.S.A.)